A Rising-Single-Dose and Multiple-Dose Safety, Tolerability, and Pharmacokinetic Study of SCH 900117 in Healthy Volunteers and in Subjects with Rheumatoid Arthritis.

Trial Profile

A Rising-Single-Dose and Multiple-Dose Safety, Tolerability, and Pharmacokinetic Study of SCH 900117 in Healthy Volunteers and in Subjects with Rheumatoid Arthritis.

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs SCH 900117 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Schering-Plough
  • Most Recent Events

    • 24 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top